NCT02475356View on ClinicalTrials.gov

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea

CompletedOBSERVATIONAL
Enrollment

601

Participants

Timeline

Start Date

August 4, 2015

Primary Completion Date

January 18, 2019

Study Completion Date

December 12, 2019

Conditions
Menorrhagia, Dysmenorrhea
Interventions
DRUG

Levonorgestrel IUS (Mirena, BAY86-5028)

The treatment of Mirena should comply with the local product information.

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY